Mar Ariza

Sep 24, 2024 | mdpi.com | Mar Ariza |Beatriz Rodriguez |Beatriz Rodríguez |Barbara Delas |Beatriz De Frutos

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Dec 21, 2023 | onlinelibrary.wiley.com | Neus Balaguer Cano |Barbara Segura |Javier Payo Bejar |Mar Ariza

Introduction Post-coronavirus disease 2019 (COVID-19) condition (PCC) is defined as the continuance or onset of new symptoms 3 months after the initial SARS-CoV-2 infection, which last at least 2 months and cannot be attributed to another cause.1 The prevalence of PCC is unknown, as it varies according to study cohorts, methodology, SARS-CoV-2 variants, and vaccination status, but it is estimated that one in eight people with COVID-19 will develop PCC.2, 3 Fatigue, dyspnea, and altered smell...